Photodynamic therapy-induced HIF-1 survival signaling (WP3614)
Homo sapiens
Photodynamic therapy may induce a hypoxic survival response mediated by HIF-1. Proteins on this pathway have targeted assays available via the CPTAC Assay Portal.
For a description of pathway objects, see the WikiPathways Legend.
Authors
Ruud Weijer , Kristina Hanspers , Friederike Ehrhart , Martina Summer-Kutmon , and Eric WeitzActivity
Discuss this pathway
Check for ongoing discussions or start your own.
Cited In
- Identification of biomarkers and pathways for the SARS-CoV-2 infections that make complexities in pulmonary arterial hypertension patients (2021).
- Identification of a global gene expression signature associated with the genetic risk of catastrophic fracture in iPSC‐derived osteoblasts from Thoroughbred horses (2025).
- Demonstration of the impact of COVID-19 on metabolic associated fatty liver disease by bioinformatics and system biology approach (2023).
Are you planning to include this pathway in your next publication? See How to Cite and add a link here to your paper once it's online.
Organisms
Homo sapiensCommunities
CPTACAnnotations
Disease Ontology
cancerPathway Ontology
altered regulatory pathwayLabel | Type | Compact URI | Comment |
---|---|---|---|
ARNT | GeneProduct | ncbigene:405 | |
PFKL | GeneProduct | ncbigene:5211 | |
SLC16A1 | GeneProduct | ncbigene:6566 | |
LDHA | GeneProduct | ncbigene:3939 | |
HIF1AN | GeneProduct | ncbigene:55662 | |
PKM2 | GeneProduct | ncbigene:5315 | |
PGK1 | GeneProduct | ncbigene:5230 | |
SLC2A1 | GeneProduct | ncbigene:6513 | |
EGLN1 | GeneProduct | ncbigene:54583 | |
HK1 | GeneProduct | ncbigene:3098 | |
SLC2A3 | GeneProduct | ncbigene:6515 | |
HIF1A | GeneProduct | ncbigene:3091 | |
SERPINE1 | GeneProduct | ncbigene:5054 | |
EDN1 | GeneProduct | ncbigene:1906 | |
NOS2 | GeneProduct | ncbigene:4843 | |
PTGS2 | GeneProduct | ncbigene:5743 | |
ANGPT1 | GeneProduct | ncbigene:284 | |
VEGFA | GeneProduct | ncbigene:7422 | |
IGFBP1 | GeneProduct | ncbigene:3484 | |
IGFBP2 | GeneProduct | ncbigene:3485 | |
TGFA | GeneProduct | ncbigene:7039 | |
TGFB3 | GeneProduct | ncbigene:7043 | |
IGFBP3 | GeneProduct | ncbigene:3486 | |
EPO | GeneProduct | ncbigene:2056 | |
ANGPT2 | GeneProduct | ncbigene:285 | |
BIRC5 | GeneProduct | ncbigene:332 | |
BCL2A1 | GeneProduct | ncbigene:597 | |
MCL1 | GeneProduct | ncbigene:4170 | |
BCL2L1 | GeneProduct | ncbigene:598 | |
BNIP3 | GeneProduct | ncbigene:664 | |
BNIP3L | GeneProduct | ncbigene:665 | |
BID | GeneProduct | ncbigene:637 | |
PMAIP1 | GeneProduct | ncbigene:5366 | |
TP53 | GeneProduct | ncbigene:7157 | |
BAX | GeneProduct | ncbigene:581 | |
BAK1 | GeneProduct | ncbigene:578 | |
PDHA1 | Protein | uniprot:P08559 |
References
- Tumor cell survival pathways activated by photodynamic therapy: a molecular basis for pharmacological inhibition strategies. Broekgaarden M, Weijer R, van Gulik TM, Hamblin MR, Heger M. Cancer Metastasis Rev. 2015 Dec;34(4):643–90. PubMed Europe PMC Scholia
- Low-power photodynamic therapy induces survival signaling in perihilar cholangiocarcinoma cells. Weijer R, Broekgaarden M, van Golen RF, Bulle E, Nieuwenhuis E, Jongejan A, et al. BMC Cancer. 2015 Dec 26;15:1014. PubMed Europe PMC Scholia